Promising combo tackles rare immune storm in adults
NCT ID NCT07531069
First seen May 13, 2026 · Last updated May 15, 2026 · Updated 1 time
Summary
This study tested whether a drug called interferon-gamma monoclonal antibody, when combined with the steroid dexamethasone, can help adults with a severe and hard-to-treat immune condition called secondary hemophagocytic lymphohistiocytosis (HLH). The study included 22 participants who received the treatment as part of their regular care. Researchers tracked their recovery through blood tests and physical exams over 8 weeks to see how well the treatment worked and if it caused any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HLH are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huadong Hospital, Fudan University
Shanghai, Shanghai Municipality, 200040, China
Conditions
Explore the condition pages connected to this study.